BACKGROUNDNo gold standard exists in the world of scientific image acquisition; a proliferation of instruments each with its own proprietary data format has made out-of-the-box sharing of that data nearly impossible. In the field of light microscopy, the Bio-Formats library was designed to translate such proprietary data formats to a common, open-source schema, enabling sharing and reproduction of scientific results. While Bio-Formats has proved successful for microscopy images, the greater scientific community was lacking a domain-independent framework for format translation.
RESULTSSCIFIO (SCientific Image Format Input and Output) is presented as a freely available, open-source library unifying the mechanisms of reading and writing image data. The core of SCIFIO is its modular definition of formats, the design of which clearly outlines the components of image I/O to encourage extensibility, facilitated by the dynamic discovery of the SciJava plugin framework. SCIFIO is structured to support coexistence of multiple domain-specific open exchange formats, such as Bio-Formats’ OME-TIFF, within a unified environment.
CONCLUSIONSSCIFIO is a freely available software library developed to standardize the process of reading and writing scientific image formats.
mGlu2 agonist |
|||
| A3601-5 | ApexBio | 5 mg | EUR 382 |
|
Description: Anti-depressants,novel potent agent |
|||
mGlu2 agonist |
|||
| A3601-5.1 | ApexBio | 10 mM (in 1mL H2O) | EUR 506.4 |
|
Description: LY2979165 is a novel potent agent that is used as Anti-depressants. LY2979165 is under clinical study. A Safety Study of LY2979165 is performing in Healthy Subjects. LY2979165 is useful for Anti-depressants. |
|||
mGlu2 agonist |
|||
| A3601-50 | ApexBio | 50 mg | EUR 2050 |
|
Description: Anti-depressants,novel potent agent |
|||
PPARδ agonist |
|||
| T12527-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: PPARδ agonist |
|||
PPARδ agonist |
|||
| T12527-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: PPARδ agonist |
|||
PPARδ agonist |
|||
| T12527-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: PPARδ agonist |
|||
PPARδ agonist |
|||
| T12527-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: PPARδ agonist |
|||
PPARδ agonist |
|||
| T12527-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: PPARδ agonist |
|||
STING agonist-10 |
|||
| T63457-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: STING agonist-10 |
|||
STING agonist-10 |
|||
| T63457-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: STING agonist-10 |
|||
STING agonist-10 |
|||
| T63457-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: STING agonist-10 |
|||
STING agonist-10 |
|||
| T63457-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: STING agonist-10 |
|||
STING agonist-10 |
|||
| T63457-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: STING agonist-10 |
|||
STING agonist-11 |
|||
| T63458-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: STING agonist-11 |
|||
STING agonist-11 |
|||
| T63458-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: STING agonist-11 |
|||
STING agonist-11 |
|||
| T63458-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: STING agonist-11 |
|||
STING agonist-11 |
|||
| T63458-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: STING agonist-11 |
|||
STING agonist-11 |
|||
| T63458-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: STING agonist-11 |
|||
STING agonist-12 |
|||
| HY-147010 | MedChemExpress | 10 mg | EUR 551.96 |
|
Description: STING agonist-12 (Compound 53) is a potent, orally active human STING activator with an EC50 of 185 nM[1]. |
|||
STING agonist-16 |
|||
| HY-131994 | MedChemExpress | 1 mg | EUR 378.79 |
|
Description: STING agonist-16 (1a) is a specific stimulator of interferon genes (STING) agonist. STING agonist-16 (1a) can be used as a potential antiviral and antitumor tool[1]. |
|||
STING agonist-22 |
|||
| HY-152955 | MedChemExpress | 1 mg | EUR 5519.57 |
|
Description: STING agonist-22 (CF501) is a potent non-nucleotide STING agonist. STING agonist-22 is a adjuvant by activating STING to induce the type I interferon (IFN-I) response and proinflammatory cytokine production. STING agonist-22 can be used as an adjuvant to boost the original protein vaccine, producing potent, broad, and long-term immune protection. STING agonist-22 can be used for SARS-CoV-2 variants and sarbecovirus diseases research[1]. |
|||
STING agonist-23 |
|||
| HY-152956 | MedChemExpress | 1 mg | EUR 811.7 |
|
Description: STING agonist-23 (CF502) is a non-nucleotide small-molecule STING agonist. STING agonist-23 activates STING, increases phosphorylation of STING, TBK1 and IRF3. STING agonist-23 promotes the levels of IFN-β, IL-6, CXCL-10, TNF-α, ISG-15, and CCL-5 in tumor cells. STING agonist-23 exhibits activity against SARS-CoV series strains[1]. |
|||
STING agonist-24 |
|||
| HY-152957 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-24 (CF504) is a non-nucleotide small-molecule STING agonist. STING agonist-23 activates STING, increases phosphorylation of STING, TBK1 and IRF3. STING agonist-23 promotes the levels of IFN-β, IL-6, CXCL-10, TNF-α, ISG-15, and CCL-5 in tumor cells. STING agonist-23 exhibits activity against SARS-CoV series strains[1]. |
|||
STING agonist-25 |
|||
| HY-152958 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-25 (CF505) is a non-nucleotide small-molecule STING agonist. STING agonist-23 activates STING, increases phosphorylation of STING, TBK1 and IRF3. STING agonist-23 promotes the levels of IFN-β, IL-6, CXCL-10, TNF-α, ISG-15, and CCL-5 in tumor cells. STING agonist-23 exhibits activity against SARS-CoV series strains[1]. |
|||
STING agonist-26 |
|||
| HY-152959 | MedChemExpress | 1 mg | EUR 743.52 |
|
Description: STING agonist-26 (CF508) is a non-nucleotide small-molecule STING agonist. STING agonist-23 activates STING, increases phosphorylation of STING, TBK1 and IRF3. STING agonist-23 promotes the levels of IFN-β, IL-6, CXCL-10, TNF-α, ISG-15, and CCL-5 in tumor cells. STING agonist-23 exhibits activity against SARS-CoV series strains[1]. |
|||
STING agonist-27 |
|||
| HY-152960 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-27 (CF509) is a non-nucleotide small-molecule STING agonist. STING agonist-23 activates STING, exhibits activity against SARS-CoV series strains[1]. |
|||
STING agonist-28 |
|||
| HY-152961 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-28 (CF510) is a non-nucleotide small-molecule STING agonist. STING agonist-23 activates STING, increases phosphorylation of STING, TBK1 and IRF3. STING agonist-23 promotes the levels of IFN-β, IL-6, CXCL-10, TNF-α, ISG-15, and CCL-5 in tumor cells. STING agonist-23 exhibits activity against SARS-CoV series strains[1]. |
|||
STING agonist-29 |
|||
| HY-152962 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-29 (CF511) is a non-nucleotide small-molecule STING agonist. STING agonist-23 activates STING, exhibits activity against SARS-CoV series strains[1]. |
|||
STING agonist-31 |
|||
| HY-153546 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-31 is a STING agonist, with EC50 values of 0.24 and 39.51 μM for h-STING and m-STING. STING agonist-31 has antitumor efficiency[1]. |
|||
STING agonist-10 |
|||
| HY-144328 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-10 (Compound 91) is a potent small molecule cyclic urea activator of STING with the EC50 of 2600 nM. Activation of STING is a highly promising approach in immunotherapy[1]. |
|||
STING agonist-11 |
|||
| HY-144329 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-11 (Compound 92) is a potent small molecule cyclic urea activator of STING with EC50 of 18 nM. Activation of STING is a highly promising approach in immunotherapy[1]. |
|||
STING agonist-15 |
|||
| HY-122568 | MedChemExpress | 500 μg | EUR 168.83 |
|
Description: STING agonist-15 (Compound STING agonist-C11) Is a STING agonist. STING agonist-15 can be used for research of cancer and immune response[1]. |
|||
STING agonist-14 |
|||
| HY-139179 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-14 (compound 12b) is a potent STING agonist that is efficacious across species. STING agonist-14 could activate the pathway by directly binding human STING. STING agonist-14 can be used for the research of tumours or viral infections[1]. |
|||
STING agonist-17 |
|||
| HY-143320 | MedChemExpress | 1 mg | EUR 3625.6 |
|
Description: STING agonist-17 (compound 4a) is a potent STING agonist with an IC50 value of 0.062 nM. STING agonist-17 has anti-cancer activity for tumor immunization[1]. |
|||
STING agonist-13 |
|||
| HY-143321 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-13 is a stimulator of interferon genes (STING) agonist, for cancer immunity via STING-mediated immune activation. STING agonist-13 can stimulate STING downstream signaling and promoting type I interferon immune responses. STING agonist-13 significantly decreases tumor volume and shows immunological memory-derived cancer inhibition[1]. |
|||
STING agonist-20 |
|||
| HY-148068 | MedChemExpress | 1 mg | EUR 5194.89 |
|
Description: STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases[1]. |
|||
STING agonist-21 |
|||
| HY-148546 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-21 (compound 1) is a STING agonist, with an EC50 of 592.8 nM. STING agonist-21 can be used for cancer research[1]. |
|||
STING agonist-30 |
|||
| HY-149267 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-30 is a potent STING agonist. STING agonist-30 exhibits STING-dependent immune activation. STING agonist-30 has extensive inhibitory effects on various viruses, including the herpes simplex virus (HSV), rotavirus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[1]. |
|||
STING agonist-34 |
|||
| HY-149781 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-34 (Compound 12L) is a potent STING agonist with an IC50 value of 1.15 μM and an EC50 of 0.38 μM in THP1 cells. STING agonist-34 could be used in cancer research[1]. |
|||
STING agonist-18 |
|||
| HY-150074 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-18 (compound 1a) can be used for synthesis of antibody-drug conjugates (ADCs), such Trastuzumab (HY-P9907) conjugate[1]. |
|||
STING agonist-19 |
|||
| HY-150075 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-19 can be used to synthesize ISAC (immune-stimulating antibody conjugates) molecule. |
|||
STING agonist-33 |
|||
| HY-153987 | MedChemExpress | Get quote | Ask for price |
|
Description: STING agonist-33 (example 1) is an agonist of STING (stimulator of interferon genes) based on 4-ethyl-2-methylthiazole-5-carboxylic acid[1]. |
|||
ROR agonist-1 |
|||
| T12750-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: ROR agonist-1 |
|||
ROR agonist-1 |
|||
| T12750-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: ROR agonist-1 |
|||
ROR agonist-1 |
|||
| T12750-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: ROR agonist-1 |
|||
ROR agonist-1 |
|||
| T12750-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: ROR agonist-1 |
|||
ROR agonist-1 |
|||
| T12750-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: ROR agonist-1 |
|||
CBR Agonist-1 |
|||
| T62583-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: CBR Agonist-1 |
|||
CBR Agonist-1 |
|||
| T62583-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: CBR Agonist-1 |
|||
CBR Agonist-1 |
|||
| T62583-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: CBR Agonist-1 |
|||
CBR Agonist-1 |
|||
| T62583-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: CBR Agonist-1 |
|||
CBR Agonist-1 |
|||
| T62583-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: CBR Agonist-1 |
|||
CBR Agonist-2 |
|||
| T62584-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: CBR Agonist-2 |
|||
CBR Agonist-2 |
|||
| T62584-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: CBR Agonist-2 |
|||
CBR Agonist-2 |
|||
| T62584-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: CBR Agonist-2 |
|||
CBR Agonist-2 |
|||
| T62584-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: CBR Agonist-2 |
|||
CBR Agonist-2 |
|||
| T62584-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: CBR Agonist-2 |
|||
ROR agonist-1 |
|||
| MBS3843033-10mg | MyBiosource | 10mg | EUR 1905 |
ROR agonist-1 |
|||
| MBS3843033-1mg | MyBiosource | 1mg | EUR 430 |
ROR agonist-1 |
|||
| MBS3843033-5mg | MyBiosource | 5mg | EUR 1165 |
ROR agonist-1 |
|||
| MBS3843033-5x10mg | MyBiosource | 5x10mg | EUR 8565 |
ROR agonist-1 |
|||
| MBS5767512-5mg | MyBiosource | 5mg | EUR 915 |
ROR agonist-1 |
|||
| MBS5767512-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
MOR agonist-1 |
|||
| HY-153471 | MedChemExpress | Get quote | Ask for price |
|
Description: MOR agonist-1 is a MOR (μ-opioid receptor) agonist. MOR agonist-1 has good analgesic effect. MOR agonist-1 can be used for the research of pain and pain-related disorders[1]. |
|||
ROR agonist-1 |
|||
| HY-128353 | MedChemExpress | Get quote | Ask for price |
|
Description: ROR agonist-1 is a potent and orally bioavailable inverse agonist of the retinoic acid receptor-related orphan receptor C2 (RORC2), inhibition of IL-17A production from human primary TH 17 cells with a pIC50 of 7.5[1]. |
|||
D4R agonist-1 |
|||
| HY-149481 | MedChemExpress | Get quote | Ask for price |
|
Description: D4R agonist-1 (Compound 16f) is a D4R partial agonist (Ki: 2.2 nM). D4R agonist-1 is metabolically stable in rat and human liver microsomes. D4R agonist-1 can be used for research of neuropsychiatric disorders[1]. |
|||
CBR Agonist-1 |
|||
| HY-151105 | MedChemExpress | Get quote | Ask for price |
|
Description: CBR Agonist-1 (27a-cis) is a cannabinoid receptor (CBR) agonist with the Ki values of 0.18 μM for CB1R and 1.22 μM for CB2R. CBR Agonist-1 (27a-cis) can be used in the study of endogenous cannabinoid system-related diseases[1]. |
|||
CBR Agonist-2 |
|||
| HY-151107 | MedChemExpress | Get quote | Ask for price |
|
Description: CBR Agonist-2 is a CB1 agonist (CB1R; CB1 ligand) with an EC50 and a Ki of 960 nM and 970 nM, respectively. CBR Agonist-2 is a promising tool for investigating the involvement of hCB1R in disorders associated with the endocannabinoid system[1]. |
|||
MOR agonist-2 |
|||
| HY-155706 | MedChemExpress | Get quote | Ask for price |
|
Description: MOR agonist-2 (compound 46) is a antagonist of D3R and agonist of MOR (Ki: 7.26 nM and 564 nM, respectively). MOR agonist-2 has the potential to produce analgesic effects through MOR partial agonism. MOR agonist-2 reduces opioid-misuse liability via D3R antagonism[1]. |
|||
MOR agonist-3 |
|||
| HY-155707 | MedChemExpress | Get quote | Ask for price |
|
Description: MOR agonist-3 (Compound 84) is a D3R/MOR antagonist (Ki 382 nM and 55.2 nM respectively). MOR agonist-3 has the potential to produce analgesic effects through MOR (μ-opioid receptor) (HY-149337) partial agonists and to reduce opioid abuse through D3R antagonists. MOR agonist-3 can be used in the treatment of inflammation and neuropathic pain research[1]. |
|||
NOP agonist-1 |
|||
| HY-156972 | MedChemExpress | Get quote | Ask for price |
|
Description: NOP agonist-1(compound 4) is a nociceptin opioid receptor (NOP) partial agonist. NOP agonist-1attenuate parkinsonian disabilities in 6-OHDA hemilesioned rats[1]. |
|||
NOP agonist-2 |
|||
| HY-156993 | MedChemExpress | Get quote | Ask for price |
|
Description: NOP agonist-2 is a selective NOP agonist[1]. |
|||
A2AR agonist-1 |
|||
| 574042 | MedKoo Biosciences | 1.0mg | EUR 310 |
LXRβ agonist-2 |
|||
| T11899-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: LXRβ agonist-2 |
|||
LXRβ agonist-2 |
|||
| T11899-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: LXRβ agonist-2 |
|||
LXRβ agonist-2 |
|||
| T11899-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: LXRβ agonist-2 |
|||
LXRβ agonist-2 |
|||
| T11899-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: LXRβ agonist-2 |
|||
LXRβ agonist-2 |
|||
| T11899-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: LXRβ agonist-2 |
|||
ERRγ agonist-1 |
|||
| T60772-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: ERRγ agonist-1 |
|||
ERRγ agonist-1 |
|||
| T60772-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: ERRγ agonist-1 |
|||
ERRγ agonist-1 |
|||
| T60772-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: ERRγ agonist-1 |
|||
ERRγ agonist-1 |
|||
| T60772-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: ERRγ agonist-1 |
|||
ERRγ agonist-1 |
|||
| T60772-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: ERRγ agonist-1 |
|||
FFA1 agonist-1 |
|||
| T62856-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: FFA1 agonist-1 |
|||
FFA1 agonist-1 |
|||
| T62856-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: FFA1 agonist-1 |
|||
FFA1 agonist-1 |
|||
| T62856-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: FFA1 agonist-1 |
|||
FFA1 agonist-1 |
|||
| T62856-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: FFA1 agonist-1 |
|||
FFA1 agonist-1 |
|||
| T62856-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: FFA1 agonist-1 |
|||
LXRβ agonist-3 |
|||
| T63989-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: LXRβ agonist-3 |
|||
LXRβ agonist-3 |
|||
| T63989-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: LXRβ agonist-3 |
|||
LXRβ agonist-3 |
|||
| T63989-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: LXRβ agonist-3 |
|||
LXRβ agonist-3 |
|||
| T63989-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: LXRβ agonist-3 |
|||
LXRβ agonist-3 |
|||
| T63989-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: LXRβ agonist-3 |
|||
FAA1 agonist-1 |
|||
| MBS3841977-100mg | MyBiosource | 100mg | EUR 840 |
FAA1 agonist-1 |
|||
| MBS3841977-10mg | MyBiosource | 10mg | EUR 255 |
FAA1 agonist-1 |
|||
| MBS3841977-50mg | MyBiosource | 50mg | EUR 630 |
FAA1 agonist-1 |
|||
| MBS3841977-5mg | MyBiosource | 5mg | EUR 200 |
FAA1 agonist-1 |
|||
| MBS3841977-5x100mg | MyBiosource | 5x100mg | EUR 3765 |
GPCR agonist-2 |
|||
| HY-47823 | MedChemExpress | 10mg | EUR 37.88 |
|
Description: GPCR agonist-2 (Compound 5j) is a GPCR GPR109b (HM74) agonist, with a pEC50 value of 6.51. GPCR agonist-2 can be used for research of lipid disorders[1]. |
|||
ERRγ agonist-1 |
|||
| HY-145848 | MedChemExpress | 10 mg | EUR 1374.48 |
|
Description: ERRγ agonist-1 is a potent ERRγ agonist. ERRγ agonist-1 increases transcriptional activities of ERRγ. ERRγ agonist-1 has the potential for the research of neuropsychological disorders[1]. |
|||
LXRβ agonist-3 |
|||
| HY-146275 | MedChemExpress | Get quote | Ask for price |
|
Description: LXRβ agonist-3 (compound 4-13) is a potent and selective LXRβ (liver X receptor β) agonist, with an EC50 of 0.095 μM. LXRβ agonist-3 efficiently inhibits U87EGFRvIII cell, with an IC50 of 3.75 μM. LXRβ agonist-3 shows antitumor activity, and can inhibit glioblastoma[1]. |
|||
SOS1 agonist-1 |
|||
| HY-153606 | MedChemExpress | 10 mg | EUR 1136.38 |
|
Description: SOS1 agonist-1 (compound 79) is an agonist for the Son of sevenless homologue SOS1. SOS1 is a guanine nucleotide exchange factor that catalyzes the exchange of GDP to GTP on RAS and regulates RAS activation. SOS1 agonists increase nucleotide exchange on RAS, enhance cellular RAS-GTP levels, and trigger biphasic signaling changes in ERK1/2 phosphorylation. Play an anti-cancer role[1]. |
|||
LXRβ agonist-2 |
|||
| HY-100469 | MedChemExpress | Get quote | Ask for price |
|
Description: LXRβ agonist-2 is a highly potent and β-selective liver X receptor (LXRβ) agonist with EC50 of 7 nM, displays 28.5-fold selectivity over LXRα (EC50=200 nM) and used in the treatment of atherosclerosis[1]. |
|||
MFN2 agonist-1 |
|||
| HY-123985 | MedChemExpress | Get quote | Ask for price |
|
Description: MFN2 agonist-1 (B-A/l) potently stimulates mitochondrial fusion in mitofusin 2 (MFN2)-deficient cells. MFN2 agonist-1 reverses mitochondrial “clumping” (formation of static mitochondrial aggregates) and restores mitochondrial motility in cultured mouse neurons expressing the CMT2A mutant MFN2 T105M. |
|||
FFA1 agonist-1 |
|||
| HY-147987 | MedChemExpress | Get quote | Ask for price |
|
Description: FFA1 agonist-1 (Compound 17a) is an orally active fatty acid receptor 1 (FFA1) agonist with an EC50 of 0.75 μM. FFA1 agonist-1 can be used for type 2 diabetes mellitus research[1]. |
|||
TLR4 agonist-1 |
|||
| HY-149650 | MedChemExpress | Get quote | Ask for price |
|
Description: TLR4 agonist-1 (compound 17a) is a potent agonist of Toll-like Receptor 4 (TLR4), and induces the generation of MIP-1β in RAW 264.7 and MM6 cells[1]. |
|||
Aβ42 agonist-1 |
|||
| HY-149763 | MedChemExpress | Get quote | Ask for price |
|
Description: Aβ42 agonist-1 (compound 7a) is a small molecule compound that can promote Aβ42 aggregation. Aβ42 agonist-1 can interact with Aβ42 oligomers and pentamers to promote nontoxic aggregate self-assembly and rapid fibril formation. Aβ42 agonist-1 prevents Aβ42-induced cytotoxicity in HT22 hippocampal neuronal cells[1]. |
|||
Aβ42 agonist-2 |
|||
| HY-149764 | MedChemExpress | Get quote | Ask for price |
|
Description: Aβ42 agonist-2 (compound 7b) is a small molecule compound that can promote Aβ42 aggregation. Aβ42 agonist-2 can interact with Aβ42 oligomers and pentamers to promote nontoxic aggregate self-assembly and rapid fibril formation. Aβ42 agonist-2 prevents Aβ42-induced cytotoxicity in HT22 hippocampal neuronal cells[1]. |
|||
LXRβ agonist-4 |
|||
| HY-152262 | MedChemExpress | Get quote | Ask for price |
|
Description: LXRβ agonist-4 is a potent, orally active Liver X receptors (LXRs) agonist with an IC50 value of 0.0078 μM for LXRβ. LXRβ agonist-4 inhibits RANKL-induced osteoclast differentiation and bone resorption. LXRβ agonist-4 can be used in research of osteoporosis[1]. |
|||
GPR3 agonist-2 |
|||
| HY-155318A | MedChemExpress | Get quote | Ask for price |
|
Description: GPR3 agonist-2(compound 32) is a potent full agonist of G protein-coupled receptor 3, with the IC50of 260 nM[1]. |
|||
STING agonist-1 |
|||
| B7835-10 | ApexBio | 10 mg | EUR 554 |
STING agonist-1 |
|||
| B7835-100 | ApexBio | 100mg | EUR 2329 |
STING agonist-1 |
|||
| B7835-5 | ApexBio | 5mg | EUR 388 |
STING agonist-1 |
|||
| B7835-50 | ApexBio | 50 mg | EUR 1663 |
GPR30 agonist-1 |
|||
| T40517-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: GPR30 agonist-1 |
|||
GPR30 agonist-1 |
|||
| T40517-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: GPR30 agonist-1 |
|||
GPR30 agonist-1 |
|||
| T40517-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: GPR30 agonist-1 |
|||
GPR30 agonist-1 |
|||
| T40517-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: GPR30 agonist-1 |
|||
GPR30 agonist-1 |
|||
| T40517-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: GPR30 agonist-1 |
|||
STING agonist-4 |
|||
| HY-123943 | MedChemExpress | 5mg | EUR 639.6 |
STING agonist-1 |
|||
| HY-19711 | MedChemExpress | 100mg | EUR 3531.6 |
STING agonist-3 |
|||
| HY-103665 | MedChemExpress | 5mg | EUR 542.4 |
TRPV4 agonist-1 |
|||
| T13214-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: TRPV4 agonist-1 |
|||
TRPV4 agonist-1 |
|||
| T13214-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: TRPV4 agonist-1 |
|||
TRPV4 agonist-1 |
|||
| T13214-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: TRPV4 agonist-1 |
|||
TRPV4 agonist-1 |
|||
| T13214-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: TRPV4 agonist-1 |
|||
TRPV4 agonist-1 |
|||
| T13214-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: TRPV4 agonist-1 |
|||
STING agonist-3 |
|||
| T13014-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: STING agonist-3 |
|||
STING agonist-3 |
|||
| T13014-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: STING agonist-3 |
|||
STING agonist-3 |
|||
| T13014-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: STING agonist-3 |
|||
STING agonist-3 |
|||
| T13014-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: STING agonist-3 |
|||
STING agonist-3 |
|||
| T13014-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: STING agonist-3 |
|||
STING agonist-4 |
|||
| T13015-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: STING agonist-4 |
|||
STING agonist-4 |
|||
| T13015-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: STING agonist-4 |
|||
STING agonist-4 |
|||
| T13015-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: STING agonist-4 |
|||
STING agonist-4 |
|||
| T13015-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: STING agonist-4 |
|||
STING agonist-4 |
|||
| T13015-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: STING agonist-4 |
|||
GPR41 agonist-1 |
|||
| T62173-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: GPR41 agonist-1 |
|||
GPR41 agonist-1 |
|||
| T62173-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: GPR41 agonist-1 |
|||
GPR41 agonist-1 |
|||
| T62173-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: GPR41 agonist-1 |
|||
GPR41 agonist-1 |
|||
| T62173-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: GPR41 agonist-1 |
|||
GPR41 agonist-1 |
|||
| T62173-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: GPR41 agonist-1 |
|||
TREM2 agonist-2 |
|||
| T62750-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: TREM2 agonist-2 |
|||
TREM2 agonist-2 |
|||
| T62750-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: TREM2 agonist-2 |
|||
TREM2 agonist-2 |
|||
| T62750-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: TREM2 agonist-2 |
|||
TREM2 agonist-2 |
|||
| T62750-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: TREM2 agonist-2 |
|||
TREM2 agonist-2 |
|||
| T62750-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: TREM2 agonist-2 |
|||
GPR52 agonist-1 |
|||
| T62787-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: GPR52 agonist-1 |
|||
GPR52 agonist-1 |
|||
| T62787-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: GPR52 agonist-1 |
|||
GPR52 agonist-1 |
|||
| T62787-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: GPR52 agonist-1 |
|||
GPR52 agonist-1 |
|||
| T62787-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: GPR52 agonist-1 |
|||
GPR52 agonist-1 |
|||
| T62787-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: GPR52 agonist-1 |
|||
TREM2 agonist-1 |
|||
| T62502-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: TREM2 agonist-1 |
|||
TREM2 agonist-1 |
|||
| T62502-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: TREM2 agonist-1 |
|||
TREM2 agonist-1 |
|||
| T62502-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: TREM2 agonist-1 |
|||